Jan 10, 2024 / 03:30PM GMT
Rachel Marie Vatnsdal Olson - JPMorgan Chase & Co, Research Division - Analyst
Perfect. Good morning, everyone. This is Rachel Vatnsdal with the Life Science Tools and Diagnostics team here at JPMorgan. Thanks so much for joining us today. I'm joined on stage by the Dentsply Sirona team. So as we typically do with these sessions, it will be 40 minutes, roughly 20 minutes of a presentation followed by 20 minutes of Q&A.
So if any of you in the room do have questions, feel free to either submit them via the portal or you can pin me it directly. And with that, I will pass it off to Simon.
Simon D. Campion - DENTSPLY SIRONA Inc. - CEO, President & Director
Good morning, everyone, and thank you, Rachel. One year into our transformation journey at Dentsply Sirona and following on the heels of our recent Investor Day, and we're pleased to be happy to provide you all an update today. On stage, I'm joined by Glenn Coleman, our Chief Financial Officer; Andreas Frank, our Chief Business Officer; and our Head of Investor Relations, Andrea Daley.
DENTSPLY SIRONA Inc at JPMorgan Healthcare Conference Transcript
Jan 23, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers